Upper endoscopy
Lose the weight. Keep everything else.
The procedure where slowed stomach emptying shows up most, and the checklist that keeps it on schedule.
Medically reviewed by Mark Nessim, MD, board-certified anesthesiologist · Last updated
Who publishes this: Habthera Nutrition, which makes ASP-1, a protein supplement. Where our product appears it is labeled as ours. Editorial policy.
Why this procedure matters most
An upper endoscopy (EGD, or "scope") passes a camera through the mouth into the stomach, usually under sedation. That makes it the procedure where slowed stomach emptying is most visible. In a 2023 study of patients who had fasted normally, 24.2% of semaglutide users still had food or significant fluid in the stomach, versus 5.1% of non-users. Nausea, bloating or indigestion before the procedure made it more likely.[1]
Food in the stomach under sedation is an aspiration risk, and it can also mean the doctor can't see well enough and the procedure has to be repeated. Actual aspiration is uncommon, and the team has several ways to plan around it, but only if they know in advance.
Your checklist
The free GLP-1 Safety Kit puts the procedure checklist on one page you can bring to your appointment, alongside protein targets and the side effects that should prompt a call to your doctor.
From Keep Everything Else, published by Habthera Nutrition. Sometimes we'll mention ASP-1, our protein supplement, and say so when we do. We never sell or share your address. Unsubscribe in one click. Who we are.
Reviewed by Mark Nessim, MD, board-certified anesthesiologist. If you tell the endoscopy office you're on a GLP-1 when you book, and tell the anesthesia team about any symptoms that morning, most people go ahead as planned.
Not on your own. Under 2024 multisociety guidance, most patients can continue GLP-1 medications. Those at higher risk, such as people who recently increased their dose or have GI symptoms, may be asked to follow a liquid diet for 24 hours. Follow your endoscopy team's instructions.
GLP-1 medications slow stomach emptying. In a 2023 study, 24.2% of semaglutide users had food or significant fluid left in the stomach at upper endoscopy despite normal fasting, versus 5.1% of non-users. Under sedation that raises the risk of aspiration.
The team may stop the procedure and reschedule it, change the anesthesia plan, or take extra steps to protect your airway. Telling them in advance about your GLP-1 and any symptoms lets them plan before the day.
Keep reading